Autism clinical trials in New York
18 active Autism trials with a site in New York. Describe your situation to see which ones look like a fit.
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
- Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
- Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
- Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder
- Transcranial Direct Current Stimulation in Children With Autism
- Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
- Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
- A Phase 2A Trial of DT402 for Autism Spectrum Disorder
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
- Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
- Longitudinal Study of Neurogenetic Disorders
- AWARE: Management of ADHD in Autism Spectrum Disorder
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
- How Virtual Reality Can Help Neurodivergent Children Improve Their Attention
- ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
- Telehealth Intervention for Autism Spectrum Disorder
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.